Clinical management of critically ill patients with Cushing’s disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

Annamaria Colao, Stephan Petersenn, John Newell‐Price et al. · New England Journal of Medicine · 2012 · 641 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial

Marco Boscaro, W.H. Ludlam, Brew Atkinson et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 279 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +15

Hyperglycemia Associated With Pasireotide: Results From a Mechanistic Study in Healthy Volunteers

Robert R. Henry, Theodore P. Ciaraldi, Debra Armstrong et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 250 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Mitotane, Metyrapone, and Ketoconazole Combination Therapy as an Alternative to Rescue Adrenalectomy for Severe ACTH-Dependent Cushing's Syndrome

Peter Kamenický, Céline Droumaguet, Sylvie Salenave et al. · The Journal of Clinical Endocrinology & Metabolism · 2011 · 220 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +12

Merits and pitfalls of mifepristone in Cushing's syndrome

Frédéric Castinetti, Sarah Johanssen, Massimo Terzolo et al. · European Journal of Endocrinology · 2009 · 160 citations

Medicine, Endocrinology, Pharmacotherapy +13